{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T05:02:36Z","timestamp":1784350956735,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:00:00Z","timestamp":1734393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.heliyon.2024.e41324","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T19:53:25Z","timestamp":1734465205000},"page":"e41324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Epidemiology, microbiology and clinical impacts of non-tuberculous mycobacteria in adult patients with cystic fibrosis"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9136-3265","authenticated-orcid":false,"given":"Zolt\u00e1n","family":"\u00d6rl\u0151s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilla Katalin","family":"L\u0151rinczi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bal\u00e1zs","family":"Antus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0067-5166","authenticated-orcid":false,"given":"Imre","family":"Barta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8577-4475","authenticated-orcid":false,"given":"Zsuzsanna","family":"Mikl\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ildik\u00f3","family":"Horv\u00e1th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e41324_bib1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4046\/trd.2018.0026","article-title":"Infection source and epidemiology of nontuberculous mycobacterial lung disease","volume":"82","author":"Jeon","year":"2019","journal-title":"Tuberc. Respir. Dis."},{"key":"10.1016\/j.heliyon.2024.e41324_bib2","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/809014","article-title":"General overview on nontuberculous mycobacteria, biofilms, and human infection","volume":"2015","author":"Faria","year":"2015","journal-title":"J Pathog"},{"key":"10.1016\/j.heliyon.2024.e41324_bib3","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1365-2672.2009.04161.x","article-title":"Surrounded by mycobacteria: nontuberculous mycobacteria in the human environment","volume":"107","author":"Falkinham","year":"2009","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.heliyon.2024.e41324_bib4","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1378\/chest.129.6.1653","article-title":"Lung disease due to the more common nontuberculous mycobacteria","volume":"129","author":"Field","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.heliyon.2024.e41324_bib5","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00535-2020","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"56","author":"Daley","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.heliyon.2024.e41324_bib6","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1055\/s-0033-1333573","article-title":"Underlying host risk factors for nontuberculous mycobacterial lung disease","volume":"34","author":"Chan","year":"2013","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.heliyon.2024.e41324_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ccm.2014.10.001","article-title":"Pathogenesis and risk factors for nontuberculous mycobacterial lung disease","volume":"36","author":"Honda","year":"2015","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.heliyon.2024.e41324_bib8","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1183\/13993003.00033-2016","article-title":"Risk of nontuberculous mycobacterial pulmonary disease with obstructive lung disease","volume":"48","author":"Marras","year":"2016","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.heliyon.2024.e41324_bib9","article-title":"Non-tuberculous mycobacteria in respiratory specimens of patients with obstructive lung diseases-colonization or disease?","volume":"9","author":"Szturmowicz","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.heliyon.2024.e41324_bib10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s40506-016-0092-6","article-title":"Nontuberculous mycobacteria in cystic fibrosis","volume":"8","author":"Skolnik","year":"2016","journal-title":"Curr. Treat. Options Infect. Dis."},{"key":"10.1016\/j.heliyon.2024.e41324_bib11","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jpeds.2016.09.064","article-title":"Diagnosis of cystic fibrosis: consensus guidelines from the cystic fibrosis foundation","volume":"181S","author":"Farrell","year":"2017","journal-title":"J. Pediatr."},{"key":"10.1016\/j.heliyon.2024.e41324_bib12","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.heliyon.2024.e41324_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms11010047","article-title":"Diagnosis and management of pulmonary NTM with a focus on Mycobacterium avium complex and Mycobacterium abscessus: challenges and prospects","volume":"11","author":"Hendrix","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.heliyon.2024.e41324_bib14","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00336-2022","article-title":"Global burden of nontuberculous mycobacteria in the cystic fibrosis population: a systematic review and meta-analysis","volume":"9","author":"Prieto","year":"2023","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.heliyon.2024.e41324_bib15","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1164\/rccm.201405-0884OC","article-title":"Nontuberculous mycobacteria among patients with cystic fibrosis in the United States: screening practices and environmental risk","volume":"190","author":"Adjemian","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.heliyon.2024.e41324_bib16","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jcf.2017.01.017","article-title":"High incidence of non-tuberculous mycobacteria-positive cultures among adolescent with cystic fibrosis","volume":"16","author":"Cavalli","year":"2017","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.heliyon.2024.e41324_bib17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijid.2023.01.032","article-title":"Epidemiological trends in nontuberculous mycobacterial infection among people with cystic fibrosis in Germany","volume":"129","author":"Steindor","year":"2023","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.heliyon.2024.e41324_bib18","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.3201\/eid1907.120615","article-title":"Prevalence of nontuberculous mycobacteria in cystic fibrosis clinics, United Kingdom, 2009","volume":"19","author":"Seddon","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.heliyon.2024.e41324_bib19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jcf.2012.06.009","article-title":"Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations","volume":"12","author":"Catherinot","year":"2013","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.heliyon.2024.e41324_bib20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jcf.2014.08.002","article-title":"Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia","volume":"14","author":"Qvist","year":"2015","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.heliyon.2024.e41324_bib21","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.rmed.2009.04.026","article-title":"Pulmonary nontuberculous mycobacterial infections: antibiotic treatment and associated costs","volume":"103","author":"Ballarino","year":"2009","journal-title":"Respir. Med."},{"key":"10.1016\/j.heliyon.2024.e41324_bib22","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/MCP.0b013e328365ab33","article-title":"Nontuberculous mycobacteria: the changing epidemiology and treatment challenges in cystic fibrosis","volume":"19","author":"Leung","year":"2013","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.heliyon.2024.e41324_bib23","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.cmi.2023.02.007","article-title":"Towards clinical breakpoints for non-tuberculous mycobacteria - determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution","volume":"29","author":"Froberg","year":"2023","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.heliyon.2024.e41324_bib24","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1128\/JCM.43.7.3467-3470.2005","article-title":"Age-related prevalence and distribution of nontuberculous mycobacterial species among patients with cystic fibrosis","volume":"43","author":"Pierre-Audigier","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.heliyon.2024.e41324_bib25","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1128\/JCM.01257-09","article-title":"Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in France","volume":"47","author":"Roux","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.heliyon.2024.e41324_bib26","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.pulmoe.2018.09.001","article-title":"Portuguese in vitro antibiotic susceptibilities favor current nontuberculous mycobacteria treatment guidelines","volume":"25","author":"Durao","year":"2019","journal-title":"Pulmonology"},{"key":"10.1016\/j.heliyon.2024.e41324_bib27","article-title":"Nontuberculous mycobacteria in Portugal: trends from the last decade","author":"Santos","year":"2022","journal-title":"Pulmonology"},{"key":"10.1016\/j.heliyon.2024.e41324_bib28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jcf.2014.05.008","article-title":"Increasing nontuberculous mycobacteria infection in cystic fibrosis","volume":"14","author":"Bar-On","year":"2015","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.heliyon.2024.e41324_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.842017","article-title":"Virulence mechanisms of Mycobacterium abscessus: current knowledge and implications for vaccine design","volume":"13","author":"Ferrell","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.heliyon.2024.e41324_bib30","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/glycob\/cwn076","article-title":"The mycobacterial glycopeptidolipids: structure, function, and their role in pathogenesis","volume":"18","author":"Schorey","year":"2008","journal-title":"Glycobiology"},{"key":"10.1016\/j.heliyon.2024.e41324_bib31","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/s12879-018-3200-z","article-title":"Clinical course and significance of nontuberculous mycobacteria and its subtypes in cystic fibrosis","volume":"18","author":"Eikani","year":"2018","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.heliyon.2024.e41324_bib32","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00578-2020","article-title":"Cystic fibrosis airway microbiota associated with outcomes of nontuberculous mycobacterial infection","volume":"7","author":"Caverly","year":"2021","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.heliyon.2024.e41324_bib33","first-page":"98","article-title":"Achromobacter xylosoxidans infection in cystic fibrosis siblings with different outcomes: case reports","volume":"20","author":"Firmida","year":"2017","journal-title":"Respir Med Case Rep"},{"key":"10.1016\/j.heliyon.2024.e41324_bib34","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jcf.2015.09.007","article-title":"Comparing the harmful effects of nontuberculous mycobacteria and Gram negative bacteria on lung function in patients with cystic fibrosis","volume":"15","author":"Qvist","year":"2016","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.heliyon.2024.e41324_bib35","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1513\/AnnalsATS.201309-310OC","article-title":"Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis","volume":"11","author":"Martiniano","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.heliyon.2024.e41324_bib36","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3201\/eid1403.061405","article-title":"Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel","volume":"14","author":"Levy","year":"2008","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.heliyon.2024.e41324_bib37","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jcf.2017.04.013","article-title":"Outcomes associated with antibiotic regimens for treatment of Mycobacterium abscessus in cystic fibrosis patients","volume":"16","author":"DaCosta","year":"2017","journal-title":"J. Cyst. Fibros."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024173550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024173550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T21:24:48Z","timestamp":1776374688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024173550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2405844024173550"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e41324","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology, microbiology and clinical impacts of non-tuberculous mycobacteria in adult patients with cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e41324","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e41324"}}